SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-056661
Filing Date
2018-09-13
Accepted
2018-09-13 16:07:54
Documents
3
Period of Report
2018-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-30022_18k.htm 8-K 27835
2 EX-99.1 a18-30022_1ex99d1.htm EX-99.1 12338
3 GRAPHIC g300221mmi001.jpg GRAPHIC 3113
  Complete submission text file 0001104659-18-056661.txt   45950
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 181068964
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1